5 hours Adial Pharmaceuticals (ADIL) Upgraded to Buy: Here’s What You Should KnowZacks
Adial Pharmaceuticals (ADIL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive the stock higher in the near term.
X